Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Mechanical Performance of a Polyaxial Locking Plate and the Influence of Screw Angulation in a Fracture Gap Model.

Kaczmarek J, Bartkowiak T, Schuenemann R, Paczos P, Gapinski B, Bogisch S, Unger M.

Vet Comp Orthop Traumatol. 2019 Oct 18. doi: 10.1055/s-0039-1698415. [Epub ahead of print]

PMID:
31627235
2.

Picturing Polarized Myeloid Phagocytes and Regulatory Cells by Mass Cytometry.

Roussel M, Bartkowiak T, Irish JM.

Methods Mol Biol. 2019;1989:217-226. doi: 10.1007/978-1-4939-9454-0_14.

PMID:
31077108
3.

Multiscale 3D Curvature Analysis of Processed Surface Textures of Aluminum Alloy 6061 T6.

Bartkowiak T, Brown CA.

Materials (Basel). 2019 Jan 14;12(2). pii: E257. doi: 10.3390/ma12020257.

4.

Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.

Jayaprakash P, Ai M, Liu A, Budhani P, Bartkowiak T, Sheng J, Ager C, Nicholas C, Jaiswal AR, Sun Y, Shah K, Balasubramanyam S, Li N, Wang G, Ning J, Zal A, Zal T, Curran MA.

J Clin Invest. 2018 Nov 1;128(11):5137-5149. doi: 10.1172/JCI96268. Epub 2018 Oct 15.

5.

Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway.

Bartkowiak T, Jaiswal AR, Ager CR, Chin R, Chen CH, Budhani P, Ai M, Reilley MJ, Sebastian MM, Hong DS, Curran MA.

Clin Cancer Res. 2018 Mar 1;24(5):1138-1151. doi: 10.1158/1078-0432.CCR-17-1847. Epub 2018 Jan 4.

6.

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.

Ager CR, Reilley MJ, Nicholas C, Bartkowiak T, Jaiswal AR, Curran MA.

Cancer Immunol Res. 2017 Aug;5(8):676-684. doi: 10.1158/2326-6066.CIR-17-0049. Epub 2017 Jul 3.

7.

Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.

Bartkowiak T, Singh S, Yang G, Galvan G, Haria D, Ai M, Allison JP, Sastry KJ, Curran MA.

Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5290-9. doi: 10.1073/pnas.1514418112. Epub 2015 Sep 8.

8.
9.

4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Bartkowiak T, Curran MA.

Front Oncol. 2015 Jun 8;5:117. doi: 10.3389/fonc.2015.00117. eCollection 2015. Review.

10.

Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer.

Schietinger A, Arina A, Liu RB, Wells S, Huang J, Engels B, Bindokas V, Bartkowiak T, Lee D, Herrmann A, Piston DW, Pittet MJ, Lin PC, Zal T, Schreiber H.

Oncoimmunology. 2013 Nov 1;2(11):e26677. Epub 2013 Nov 4.

11.

Natural recovery from antiglomerular basement membrane glomerulonephritis is associated with glomeruli-infiltrating CD8α+CD11c+MHC class II+ cells.

Zhou C, Robertson J, Wu J, Bartkowiak T, Parker K, McMahon J, Lou YH.

Am J Nephrol. 2011;34(6):519-28. doi: 10.1159/000333004. Epub 2011 Nov 7.

12.

Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis.

Zhou C, Wu J, Torres L, Hicks JM, Bartkowiak T, Parker K, Lou YH.

Am J Nephrol. 2010;32(4):324-31. doi: 10.1159/000319490. Epub 2010 Aug 19.

13.

Osteopontin overproduction is associated with progression of glomerular fibrosis in a rat model of anti-glomerular basement membrane glomerulonephritis.

Merszei J, Wu J, Torres L, Hicks JM, Bartkowiak T, Tan F, Lou YH.

Am J Nephrol. 2010;32(3):262-71. doi: 10.1159/000319238. Epub 2010 Aug 12.

Supplemental Content

Loading ...
Support Center